Gara Jalqabaatti › Kansara Metastatikii › Virginia › Charlottesville
Qorannoo klinikaalii Kansara Metastatikii Charlottesville, VA keessatti
Qorannoo 13 Kansara Metastatikii f Charlottesville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Namoota walitti qabaa jiraSadarkaa 2/3
- University of Virginia, Charlottesville
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Charlottesville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UVA Comprehensive Cancer Center, Charlottesville
- UVA Health Fontaine Research Park, Charlottesville
- University of Virginia, Charlottesville
- fi 1 dabalataa
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia Health System, Charlottesville
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Virginia, Charlottesville
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Crinetics Study Site, Charlottesville
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Virginia, Charlottesville
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Charlottesville
A Study of NX-1607 in Adults With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Washington, DCQorannoo 43
- Dallas, TXQorannoo 42
Qorannoo biroo Charlottesville keessatti
- Kansara Qara'a Non-Small CellQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 16
- Kansarii ProstateQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 13
- Kansa EndometiriyaaliiQorannoo 13
- Dhibee QaraQorannoo 13
- Cufama OnneeQorannoo 12
- Kansarii ColorectalQorannoo 10
- Kansarii OvariiQorannoo 10
- Diabetes Type 1Qorannoo 9
- Saree OljooQorannoo 9
- Kansarii PancreasQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.